All In Biotech

Drug Trial Radar · NCT05071612

Parallel Arm Trial of AD109 and AD504 In Patients With OSA

Phase 2 Randomized Double-Blind Placebo-Controlled Parallel-Arm Dose Finding Study to Compare Fixed Dose Combinations of AD109 and AD504 to Atomoxetine or Placebo in Obstructive Sleep Apnea

Last checked: Nov 19, 2026Latest source record: Aug 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 294 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

294

Actual

Start

Nov 29, 2021

Primary completion

Jul 20, 2022

Study completion Aug 3, 2022

Sponsor

Lead sponsor
ApnimedIndustry
Sponsor type
Industry
First posted
Oct 8, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase 2 randomized double-blind placebo-controlled parallel-arm dose finding study to compare fixed dose combinations of AD109 and AD504 to atomoxetine or placebo in Obstructive Sleep Apnea.

Conditions

  • OSA - Obstructive Sleep Apnea

Interventions

  • AD109Drug

    Oral administration at bedtime

  • AD504Drug

    Oral administration at bedtime

  • Atomoxetine HydrochlorideDrug

    Oral administration at bedtime

  • PlaceboDrug

    Oral administration at bedtime

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Apnea-Hypopnea Index (AHI4) From Baseline: Combined AD109 Arms vs. PlaceboTime frame: Baseline (mean of PSG Visits 2 and 3) to Day 21 and Day 28 (PSG Visits 5 and 6)

Locations

25 sites in 1 country. Site status is shown where the registry gives one.

  • Santa Monica Clinical Trials

    Los Angeles, California

  • Pacific Research Network

    San Diego, California

  • SDS Clinical Trials, Inc.

    Santa Ana, California

  • Delta Waves

    Colorado Springs, Colorado

  • Teradan Clinical Trials

    Brandon, Florida

  • Research Centers of America -- Hollywood

    Hollywood, Florida

  • Sleep Medicine Specialists of South Florida

    Miami, Florida

  • NeuroTrials Research, Inc.

    Atlanta, Georgia

  • Chicago Research Center

    Chicago, Illinois

  • The Center for Sleep & Wake Disorders

    Chevy Chase, Maryland

  • Sleep Disorders Centers of the Mid-Atlantic (SDCMA)

    Glen Burnie, Maryland

  • Neurocare

    Newton, Massachusetts

  • Henry Ford Hospital

    Detroit, Michigan

  • Sleep and Attention Disorders Institute

    Sterling Heights, Michigan

  • Minnesota Lung Center / Minnesota Sleep Institute

    Woodbury, Minnesota

  • St. Luke's Hospital Sleep Medicine

    Chesterfield, Missouri

  • Clayton Sleep Institute

    Maplewood, Missouri

  • Clinilabs

    New York, New York

  • Coastal Carolina Health Care, P.A.

    New Bern, North Carolina

  • CTI Clinical Research Center

    Cincinnati, Ohio

  • Intrepid Research

    Cincinnati, Ohio

  • Brian Abaluck, LLC

    Malvern, Pennsylvania

  • Bogan Sleep Consultants LLC

    Columbia, South Carolina

  • Velocity Clinical Research

    Greenville, South Carolina

  • FutureSearch Trials of Neurology

    Austin, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.